AnalystsAndrea Tan
Andrea Tan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4948 out of 5014 analysts
Average Return
-15.1%
Win Rate
38%14 out of 37
Risk vs Reward
Poor
Good

Andrea Tan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Insmed IncINSM
+163.18%$24.93$65.61
2024-05-15 -
2025-05-14
Strong Buy
Fate Therapeutics IncFATE
+79.03%$14.21$2.98
2022-12-15 -
2023-12-14
Strong Sell
Relmada Therapeutics IncRLMD
+75.07%$2.96$0.74
2024-06-05 -
2025-06-04
Strong Sell
Krystal Biotech IncKRYS
+69.74%$104.78$177.85
2023-11-20 -
2024-11-19
Strong Buy
Codiak Biosciences IncCDAKQ
+68.78%$9.29$15.68
2020-11-09 -
2021-11-08
Strong Buy

Andrea Tan Analyst Color

Get additional color on Andrea Tan's coverage of popular stocks

Andrea Tan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Insmed IncINSM
7Strong Buy$142.00-2.69%Maintains
a month ago
Iovance Biotherapeutics IncIOVA
7Strong Buy$8.00+252.42%Maintains
4 months ago
Tarsus Pharmaceuticals IncTARS
4Hold$51.00+3.32%Maintains
4 months ago
Day One Biopharmaceuticals IncDAWN
6Strong Buy$27.00+279.21%Maintains
6 months ago
Sagimet Biosciences IncSGMT
5Hold$6.00N/AMaintains
a year ago
Arrowhead Pharmaceuticals IncARWR
1Hold$31.00N/AInitiates Coverage On
a year ago
Relmada Therapeutics IncRLMD
3Strong Sell$2.00N/ADowngrades
a year ago
Kodiak Sciences IncKOD
1Strong Sell$2.00N/AReinstates
2 years ago
Immunogen IncIMGN
1Hold$17.00N/AInitiates Coverage On
2 years ago
Krystal Biotech IncKRYS
1Strong Buy$160.00N/AInitiates Coverage On
2 years ago
Abcellera Biologics IncABCL
2Strong Buy$24.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
2Strong Sell$4.00N/AMaintains
3 years ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$375.00N/AMaintains
3 years ago
Verve Therapeutics IncVERV
1Strong Sell$13.00N/AInitiates Coverage On
3 years ago
Codiak Biosciences IncCDAKQ
5Hold$1.40N/AMaintains
3 years ago
Vor Biopharma IncVOR
1Hold$6.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.